Metraipolis › archive › dc_40fbbef59cf6

Pharmacokinetics of hyaluronidase-facilitated subcutaneous immunoglobulin 10% in pediatric patients with primary immunodeficiency disease — Europe PMC PMID:41937917

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41937917
DOI: 10.1093/immadv/ltag003
License (as archived): solo-consultazione
Archived: 2026-11-03T09:51:47.454Z
SHA-256 of the archived text: 5292939a62cf5a7c5b8af17c4c4282e076ab5a529c04bb7c037839e7e6eb9de9
Stable URL of this page: https://metraipolis.com/documento/dc_40fbbef59cf6

How to cite

Pharmacokinetics of hyaluronidase-facilitated subcutaneous immunoglobulin 10% in pediatric patients with primary immunodeficiency disease — Europe PMC PMID:41937917 — Europe PMC (en), https://europepmc.org/article/MED/41937917 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_40fbbef59cf6 (Metraipolis archive dc_40fbbef59cf6, sha256 5292939a62cf5a7c5b8af17c4c4282e076ab5a529c04bb7c037839e7e6eb9de9)

BibTeX

@misc{dc40fbbef59cf6,
  title = {Pharmacokinetics of hyaluronidase-facilitated subcutaneous immunoglobulin 10% in pediatric patients with primary immunodeficiency disease — Europe PMC PMID:41937917},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41937917},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_40fbbef59cf6; sha256 5292939a62cf5a7c5b8af17c4c4282e076ab5a529c04bb7c037839e7e6eb9de9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41937917. Agents can read the archived copy with the MCP tool read_document.